Myopia Control Solutions
Myopia Control Process
We start with a professional assessment and then recommend the most suitable myopia control solutions and suggestions for you.

Professional Assessment

Visual Hygiene & Lifestyle Suggestions

Myopia Control Glasses and Contact Lenses

Regular Follow-up
Myopia Control Glasses
Defocus Incorporated Multiple Segments (DIMS)
DIMS technology is the first myopia control spectacle lens that uses a lens array design. It incorporates hundreds of small lenses around the central area. Looking through the central lens provides clear vision, while the surrounding peripheral lenses create defocused images in front of the retina. DIMS can suppress excessive eye growth through a physiological feedback mechanism.
- Slows axial elongation by 62%
- Slows myopia progression by 52%
Highly Aspherical Lenslet Target (HALT)
H.A.L.T. technology is a variant of lens array design. It provides both vision correction and peripheral defocus through the center area of non-spherical lenses and 11 concentric rings, effectively slowing down axial elongation and myopia progression.
- Slows axial elongation by approximately 51%–60%
- Slows myopia progression by approximately 55%–67%
Myopia Control Contact Lenses
Orthokeratology (Ortho-K) Lenses
Ortho-K lenses reduce myopia by changing the shape of the cornea and slows down the progression of myopia with the following features:
-
- Rigid, high oxygen permeable contact lenses worn at bedtime
- Glasses or contact lenses are not required the next morning
- Slows axial elongation by approximately 43% – 63%
Dual-Focus Soft Contact Lenses
Dual-focus soft contact lenses are designed to slow down myopia progression. Multiple different powered concentric rings create peripheral defocus, which, through a feedback mechanism, prevents excessive eye growth.
- Daytime wear for myopia correction
- Daily disposable lenses or lenses to be replaced every 3 months
- Slows axial elongation by 52% – 58%
- Slows myopia progression by 58% – 59%
Low-Dose Atropine
Atropine can slow down myopia progression but may have side effects. Studies on appropriate dosage are ongoing. According to clinical experiments:
| 0.05% concentration | 0.025% concentration | 0.01% concentration | |
| Slowing axial elongation | 53.5% | 32.6% | 18.6% |
| Slowing myopia progression | 64.5% | 42.2% | 27.7% |
Combined Treatment
Our optometrists will carefully assess whether combination therapy is appropriate to achieve the best possible myopia control outcomes for your child.